SCHEMBL15034009

SCHEMBL15034009

CC1(C)CNCCN1C(=O)c1nnn(-c2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.36
ABCG2 Q9UNQ0 9/20 0.36
CPT1A P50416 2/20 0.34
ABCB1 P08183 4/20 0.33
SIGMAR1 Q99720 2/20 0.33
HTR3E A5X5Y0 1/20 0.31
HTR3B O95264 1/20 0.31
ADRB1 P08588 1/20 0.31
HTR3A P46098 1/20 0.31
HTR3D Q70Z44 1/20 0.31
HTR3C Q8WXA8 1/20 0.31
CPT2 P23786 1/20 0.31
ALDH1A1 P00352 2/20 0.31
TSHR P16473 2/20 0.31
USP2 O75604 1/20 0.31
HSD17B10 Q99714 1/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL15019509 0.94 ABCG2 (0.33) HPGDABCG2CPT1AABCB1KDM4E
SCHEMBL15019853 0.88 HTR3E (0.40) SIGMAR1HTR3EHTR3BADRB1HTR3A
SCHEMBL15034010 0.87 NOTUM (0.34) ALDH1A1USP2MMP2
Trifluoroacetic Acid SCHEMBL15020080 0.84 NOTUM (0.33) ALDH1A1USP2PKMMMP2
Trifluoroacetic Acid SCHEMBL15022303 0.84 C1S (0.39) SIGMAR1HTR3EHTR3BADRB1HTR3A
SCHEMBL15020073 0.79 MAPT (0.42) HPGDALDH1A1HSD17B10
SCHEMBL3712349 0.76 SIGMAR1 (0.54) HPGDSIGMAR1ALDH1A1TSHRUSP2
SCHEMBL15034212 0.71 IRAK4 (0.36) PKM
SCHEMBL15019517 0.71 IRAK4 (0.36) HPGDABCG2ALDH1A1TSHRKDM4E
SCHEMBL15034208 0.71 PKM (0.42) ALDH1A1TSHRKDM4ELMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883789-B2 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-11 US disclosed
US-8883789-B2 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-11-11 US disclosed
US-20130158042-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 US disclosed
US-20130158042-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158042-A1 NOVEL COMPOUNDS GRM5, GRIK5, GRM1 HPGD 2696/4885ABCG2 898/4885CPT1A 1103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.